World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615000507583
Date of registration: 20/05/2015
Prospective Registration: No
Primary sponsor: "Grigore Alexandrescu” Children Emergency Hospital
Public title: Effects of oligofructose and inulin in management of chronic nonspecific diarrhoea of childhood – intervention study
Scientific title: Safety and efficacy of a combination of oligofructose and inulin used for chronic nonspecific diarrhoea of childhood when compared with dietary recommendations
Date of first enrolment: 07/11/2012
Target sample size: 54
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12615000507583.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Safety/efficacy;  
Phase:  Not Applicable
Countries of recruitment
Romania
Contacts
Name: Dr Tincu Iulia Florentina   
Address:  "Grigore Alexandrescu” Children Emergency Hospital, 30-32 Iancu de Hunedoara Boulevard, zip code 11743, Bucharest Romania
Telephone: +40725535100
Email: if_boian@yahoo.com
Affiliation: 
Name: Dr Becheanu Cristina Adriana   
Address:  "Grigore Alexandrescu” Children Emergency Hospital, 30-32 Iancu de Hunedoara Boulevard, zip code 11743, Bucharest Romania
Telephone: +40213169366
Email: cbecheanu@yahoo.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: (1) age 1 to 5 years
(2) at least 5 episodes of diarrhoea in the last 6 months
(3) normal weight and length for age
(4) normal development

Exclusion criteria: comorbidities of any kind
abnormal nutritional status
acute infections
food allergies
coeliac disease
inflammatory bowel disease
gastrointestinal malformation


Age minimum: 1 Years
Age maximum: 5 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Chronic nonspecific diarrhoea of childhood;
Chronic nonspecific diarrhoea of childhood
Intervention(s)
Name of intervention: oral supplement of 4 g of inulin enriched with oligofructose (1/1, 2g oligofructose and 2g inulin per day), 1 sachet/day, for 3 months consecutively

Strategy used to monitor adherence to the intervention: sachets return
Primary Outcome(s)
Primary Outcome 1: duration of acute episodes in chronic nonspecific diarrhoea
acute episode: defined as increased stool frequency with changes of stool consistency appreciated according to the Bristol Stool Form Scale, where 1 represents hard stools, 7 indicates watery stools, scores lower than 5 indicate normal stool
duration of acute episodes: is defined as the time from the first loose stool, until at least 12 hours without stool.[Timepoint: during intervention and 3 months after intervention stopped
]
Primary Outcome 2: severity of acute episode in chronic nonspecific diarrhoea evaluated by association of symptoms: vomiting, abdominal pain, constipation; this was marked with Yes/No answers and counted as episodes per period between visits[Timepoint: during intervention and 3 months after intervention stoped ]
Secondary Outcome(s)
hospitalization : yes/no answers, duration of hospitalization in days[during the follow up procedure]
use of antibiotics for any reasons, acute infections during the follow up procedure; the first one refers to intestinal infections and the second one refers to use of antibiotics in general[during intervention and 3 months after intervention stoped]
Need for antibiotic use for acute infectious intestinal episodes[Timepoint: during intervention and 3months after intervention stoped ]
safety and efficiency of the supplement appreciated by a questionnaire completed by parents in terms of treatment efficiency and acceptance (very good/ good/ moderate were the answers options).[during intervention and 3 months after intervention stoped]
Secondary ID(s)
Nil known
Source(s) of Monetary Support
"Grigore Alexandrescu” Children Emergency Hospital
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Ethics Committee of : "Grigore Alexandrescu” Children Emergency Hospital
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history